Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
NAD refers Generix Labs’ BiphedAdrene ads to FTC; ABCO Labs cited for misbranded and unapproved new drugs; FDA warns RockStar on beverage additives; more Regulatory News In Brief.